Scarica l'app Stockscreener
38.16
0.57%
-0.22
Dopo l'orario di chiusura:
38.50
0.34
+0.89%
Precedente Chiudi:
$38.38
Aprire:
$38.27
Volume 24 ore:
429.41K
Relative Volume:
0.93
Capitalizzazione di mercato:
$1.89B
Reddito:
$3.53B
Utile/perdita netta:
$30.99M
Rapporto P/E:
62.21
EPS:
0.6134
Flusso di cassa netto:
$154.99M
1 W Prestazione:
-1.47%
1M Prestazione:
-0.26%
6M Prestazione:
+68.55%
1 anno Prestazione:
+54.74%
Intervallo 1D:
$37.75
$38.87
Intervallo di 1 settimana:
$37.27
$40.13
Portata 52W:
$18.08
$40.13
Astrana Health Inc Stock (ASTH) Company Profile
Nome
Astrana Health Inc
Settore
Industria
Telefono
(626) 282-0288
Indirizzo
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, DVA, FMS, EHC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ASTH
Astrana Health Inc
|
38.16 | 1.90B | 3.53B | 30.99M | 154.99M | 0.6134 |
HCA
Hca Healthcare Inc
|
388.16 | 86.51B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
178.50 | 15.43B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
210.58 | 13.46B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
23.57 | 12.60B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
97.89 | 9.86B | 6.07B | 793.80M | 464.40M | 5.9914 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-12 | Iniziato | Needham | Buy |
| 2025-04-01 | Iniziato | Barclays | Equal Weight |
| 2024-10-14 | Iniziato | TD Cowen | Buy |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2024-07-11 | Aggiornamento | Truist | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-26 | Iniziato | Jefferies | Buy |
| 2024-02-22 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-01-24 | Iniziato | Stifel | Buy |
| 2023-12-22 | Iniziato | Truist | Hold |
| 2023-10-17 | Iniziato | BTIG Research | Buy |
| 2023-04-12 | Iniziato | BofA Securities | Neutral |
| 2022-12-19 | Iniziato | Lake Street | Buy |
| 2022-09-21 | Iniziato | William Blair | Outperform |
| 2022-01-11 | Ripresa | Colliers Securities | Buy |
| 2021-08-12 | Iniziato | Barclays | Equal Weight |
Mostra tutto
Astrana Health Inc Borsa (ASTH) Ultime notizie
Is Astrana Health Inc (ASTH) a Bargain After 3.1% Drop? GF Value Says Undervalued - GuruFocus
Astrana Health (ASTH) director receives 4,525 restricted stock award - Stock Titan
Director Mazdyasni granted 4,525 Astrana Health (ASTH) restricted shares vesting in 2027 - Stock Titan
Astrana Health (ASTH) director gets 4,991 new restricted shares - Stock Titan
Astrana Health (ASTH) director Weili Dai receives 4,525-share restricted stock grant - Stock Titan
[Form 4] Astrana Health, Inc. Insider Trading Activity - Stock Titan
Astrana Health stock hits 52-week high at 39.97 USD By Investing.com - Investing.com Nigeria
ASTH Stock Price, Quote & Chart - ChartMill
Astrana Health stock hits 52-week high at 39.97 USD - Investing.com
ASTH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Astrana Health (ASTH) investors approve expanded 2024 equity incentive plan to 2036 - Stock Titan
Will First-Time Fortune 1000 Status Reshape Astrana Health's (ASTH) Value-Based Care Investment Narrative? - simplywall.st
Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth - PR Newswire
AI-driven Astrana Health hits $3.18B revenue, now a Fortune 1000 company - Stock Titan
ASTH Reiterated by BTIG -- Price Target Maintained at $50.00 - GuruFocus
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Astrana Health (ASTH) price target increased by 18.07% to 44.43 - MSN
Astrana Health, Inc. (ASTH) Misses Q3 Earnings Estimates - MSN
Astrana Health names George Christides interim medical director By Investing.com - Investing.com Nigeria
Astrana Health Raised to Overweight From Equal-Weight by Barclays - Moomoo
A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack - Yahoo Finance
Astrana Health Q1 2026 slides: 56% revenue growth, full-risk shift accelerates - Investing.com Nigeria
Astrana Health closes deal with Prospect Health at a lower price - MSN
Does Astrana’s AI Partnership With California Physicians Reshape the Bull Case for Astrana Health (ASTH)? - Sahm
A Look at Astrana Health Inc (ASTH) After 3.5% Decline -- GF Val - GuruFocus
Cash-Rich Stocks: Appian and Array Face Challenges, Astrana Health ShinesNews and Statistics - IndexBox
Is Astrana’s Q1 Results and AI Platform Push Altering The Investment Case For Astrana Health (ASTH)? - Yahoo Finance
52-Week High Stocks: Sell EchoStar, Watch Vita Coco and Astrana HealthNews and Statistics - IndexBox
Astrana Health (ASTH) COO and CFO surrenders 8,155 shares for tax withholding - Stock Titan
Astrana Health partners with California physician group By Investing.com - Investing.com Nigeria
Astrana Health says Prospect deal is ahead of schedule as Q1 trends beat expectations - MSN
Astrana Health Q1 2026 Results: Revenue Beat and AI-Driven Growth - IndexBox
5 Revealing Analyst Questions From Astrana Health’s Q1 Earnings Call - Yahoo Finance
Will Strong Q1 Results and New Leadership Shift Astrana Health's (ASTH) Value-Based Care Narrative - simplywall.st
Baird Lifts PT on Astrana Health (ASTH) Following Q1 Results - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Astrana Health (ASTH), Bristol-Myers Squibb (BMY) and Progyny (PGNY) - The Globe and Mail
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $47 - Moomoo
Truist raises Astrana Health stock price target to $47 on outlook - Investing.com UK
Truist raises Astrana Health stock price target to $47 on outlook By Investing.com - Investing.com South Africa
BofA Securities Maintains Astrana Health(ASTH.US) With Buy Rating - Moomoo
Astrana Health Updates Investor Presentation via Regulation FD Disclosure - The Globe and Mail
Astrana Health Inc Azioni (ASTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Astrana Health Inc Azioni (ASTH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Schmidt David | Director |
Jan 13 '26 |
Option Exercise |
5.79 |
20,000 |
115,800 |
35,763 |
| Lam Thomas S. | Director |
Dec 08 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
459,122 |
| Sim Kenneth T. | Executive Chairman |
Nov 10 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
639,407 |
| Kitayama Mitchell W | Director |
Nov 07 '25 |
Option Exercise |
18.20 |
12,000 |
218,400 |
27,846 |
| Mazdyasni Matthew | Director |
Nov 10 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
34,763 |
| Marsh Linda | Director |
Nov 03 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
103,641 |
| Kitayama Mitchell W | Director |
Sep 15 '25 |
Option Exercise |
18.20 |
8,000 |
145,600 |
29,060 |
| Schmidt David | Director |
Sep 02 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
35,763 |
| Chiang John | Director |
Aug 13 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
43,132 |
0.28%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):